Some important publications#


H factor: 43 (Web of Knowledge, summer 2012)

1. Yazici H, Chamberlain MA, Tüzün Y, Yurdakul S,Müftüoğlu A. A comparative study of the pathergy reaction among Turkish and British patients with Behçet’s disease. Ann Rheum Dis l984; 43: 74-75.

2. Yazici H, Pazarlı H, Barnes CG, Tüzün Y, Ozyazgan Y, Silman A, Serdaroğlu S, Oğuz V, Yurdakul S, Lovatt G, Yazıcı B, Somani S and Müftüoğlu A. A controlled trial of Azathioprine in Behçet’s syndrome. N Engl J Med l990; 322: 28l-285.

3. Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Ann Intern Med l998; 128: 443-450.

4. Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H. The long-term mortality and morbidity of Behçet syndrome. A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82: 60-76.

5. Yazici Y, Adler NM, Yazici H. Most tumour necrosis factor inhibitor trials in rheumatology are undeservedly called 'efficacy and safety' trials: a survey of power considerations. Rheumatology (Oxford). 2008; 47 (7):1054-1057.

6. Hatemi G, Fresko I, Tascilar K, Yazici H. Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum. 2008 ;58(5):1539-1545.

7. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gül A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H. Management of Behcet's disease: a systematic literature review for the EULAR evidence based recommendations for the management of Behcet's disease. Ann Rheum Dis. 2009;68(10):1528-1534.

8. Yazici Y, Yazici H. Informed consent: time for more transparency. Arthritis Res Ther. 2010 ; 3;12(3):121.

9. Karaca M, Hatemi G, Sut N, Yazici H. The papulopustular lesion/arthritis cluster of Behcet's syndrome also clusters in families. Rheumatology (Oxford). 2012 Jan 27. [Epub ahead of print]]

10. Behçet's Syndrome. Editors Yazici Y, Yazici H Springer, New York, 2010



Publications 2, 3, 4 and 7 have become the main literature sources on how we prognosticate and manage Behçet's syndrome today and have been most instrumental in the recognition of the candidate as an international expert in his field.

Publications 1 and 7 are examples for collaborative studies in Europe

Publications 5 and 8 are examples for the candidate's interest in research methodology and ethics

Publications 6 and 9 are examples for the candidate's on going clinical research activity in his field.

Publication 10 is an authoritative, multi authored treatise on Behçet's syndrome.

Imprint Privacy policy « This page (revision-2) was last updated on Saturday, 29. September 2012, 10:58 by Maurer Hermann
  • operated by